A Delphi survey to determine a definition and description of hyperacusis by clinician consensus.

Sound tolerance psychoacoustics/hearing science sound sensitivity uncomfortable loudness levels

Journal

International journal of audiology
ISSN: 1708-8186
Titre abrégé: Int J Audiol
Pays: England
ID NLM: 101140017

Informations de publication

Date de publication:
08 2021
Historique:
pubmed: 12 12 2020
medline: 16 10 2021
entrez: 11 12 2020
Statut: ppublish

Résumé

There is currently no singularly accepted definition of hyperacusis. The aim of this study was to determine a definition and description of hyperacusis by clinician consensus. A three-round Delphi survey involving hearing healthcare professionals built towards clinical consensus on a definition of hyperacusis. Round 1 involved three open-ended questions about hyperacusis. Seventy-nine statements were generated on descriptions, impact, sounds, and potential features of hyperacusis. Agreement on the relevance of each statement to defining or describing hyperacusis was then measured in Rounds 2 and 3. General consensus was defined a priori as ≥70% agreement, or ≥90 for clinical decision making. Forty-five hearing healthcare professionals were recruited to take part in this study. Forty-one completed Round 1, 36 completed Round 2, and 33 completed Round 3. Consensus was reached on 42/79 statements. From these a consensus definition includes "A reduced tolerance to sound(s) that are perceived as normal to the majority of the population or were perceived as normal to the person before their onset of hyperacusis". A consensus description of hyperacusis was also determined. This consensus definition of hyperacusis will help to determine the scope of clinical practice guidelines and influence needed research on hyperacusis.

Identifiants

pubmed: 33305628
doi: 10.1080/14992027.2020.1855370
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

607-613

Auteurs

Bethany Adams (B)

National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, Nottingham, UK.
Hearing Sciences, Division of Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham, UK.

Magdalena Sereda (M)

National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, Nottingham, UK.
Hearing Sciences, Division of Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham, UK.

Amanda Casey (A)

Audiology, Aston University, Aston Triangle, Birmingham, UK.

Peter Byrom (P)

Peter Byrom Audiology Ltd, Thornbury Hospital, Sheffield, UK.

David Stockdale (D)

British Tinnitus Association, Sheffield, UK.

Derek J Hoare (DJ)

National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, Nottingham, UK.
Hearing Sciences, Division of Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH